Parameter Estimation and Dosage Adjustment in the Treatment with Vancomycin of Methicillin-Resistant Staphylococcus aureus Ocular Infections

Ophthalmologica

Volumn 211, Issue 4, 1997, Pages 232-235

  Saitoh, Akira ^a   Jinbayashi, Hiromi ^a   Saitoh, Ayumi Kondoh ^a   Ohira, Akihiro ^a   Amemiya, Tsugio ^a   Etoh, Kazuhiro ^b   Matsuyama, Kenji ^b   Ichikawa, Masataka ^b  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Methicillin resistant staphylococcus; Parameter estimation and dosage adjustment (PEDA) program; Sawchuck Zaske equation; Vancomycin

Indexed keywords

MINOCYCLINE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CASE REPORT; DACRYOCYSTITIS; DRUG DOSE; ENDOPHTHALMITIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; TOPICAL DRUG ADMINISTRATION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DACRYOCYSTITIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPHTHALMITIS; EYE INFECTIONS; FEMALE; HUMANS; INFANT; METHICILLIN RESISTANCE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 0030999324     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000310797     Document Type: Article

References (12)

1. Callcgan MC, Hill JM, Insler MS, Hobden JA, O'Callagham RJ: Melhicillin-resistant Staphylococcus aureus keratitis in the rabbit: Therapy with ciprofloxacin, vancomycin and ccfazolin. CurrEye Res 1992:11:1111-1119.
2. Fiferman RA, O'Neill KP, Morrison NA: Meth-icillin-resistant Staphylococcus aureus corneal ulcers. Ann Ophthalmol 1991:23:414-415.
3. Ooishi M: MRSA ocular infections. Folia Ophthalmol Jpn 1990:41:18-25.
4. Sawchuck RJ, Zaske OF: Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: Gentamicin in burn patients. J Pharmacokinet Biopharm 1976:4:183-195.
5. Higuchi S. Aoyama T. Ilorioka M: PFDA: A microcomputer program for parameter estimation and dosage adjustment in clinical practice. J Pharmacobiodynam 1987:10:703-718.
6. Nishijima S. Namura S. Kawai S. Akamatsu H. Asada Y. Kawahata S: Sensitivity of Staphylococcus aureus and Streptococcus pyogenes isolated from skin infections in 1992 to antimicrobial agents. J Dermatol 1994:21:233-238.
7. Hashimoto H, Hayashi I, Inouye M: A survey of Staphylococcus aureus for typing and drug resistance in various areas of Japan during 1992 and 1993. Jpn J Antibiot 1994:47:618-626.
8. Inouye Y, Morifuji K, Takcsue Y, Santou T, Ma-sui N, Yokoyama T, Nakamura S: Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolation to various antimicrobial agents. II. Isolation of arbekacin-resistant strain. Hiroshima J Med Sci 1992;41:79-85.
9. Pryor JG. Apt L. Leopold IH: Intraocular penetration of vancomycin. Arch Ophthalmol 1962; 67:608-611.
10. Mellor JA, Kingdom J, Cafferkey M, Keane CT: Vancomycin toxicity: A prospective study. J Antimicrob Chemother 1985:15:773.
11. Matzke GR, Zhanel GG, Guay DR: Clinical pharmacokinetics of vancomycin. Clin Pharmacokinet 1986:11:257-282.
12. Mocllering RC Jr. Krogstad DJ. Greenblatt DJ: Vancomycin therapy in patients with impaired renal function: A nomogram for dosage. Ann Intern Med 1981;94:343-346.